ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 100 filers reported holding ANTARES PHARMA INC in Q2 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $82,000 | -32.8% | 19,920 | -23.3% | 0.01% | -50.0% |
| Q4 2019 | $122,000 | -9.0% | 25,975 | -34.9% | 0.01% | +20.0% |
| Q3 2019 | $134,000 | -71.4% | 39,920 | -72.0% | 0.01% | -63.0% |
| Q2 2019 | $469,000 | +942.2% | 142,607 | +759.0% | 0.03% | +1250.0% |
| Q4 2018 | $45,000 | +15.4% | 16,601 | +9.6% | 0.00% | 0.0% |
| Q2 2018 | $39,000 | -66.7% | 15,151 | -74.1% | 0.00% | -66.7% |
| Q4 2017 | $117,000 | – | 58,575 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 4,598,329 | $10,852,000 | 4.99% |
| Soleus Capital Management, L.P. | 864,100 | $2,039,000 | 2.37% |
| Healthcare Value Capital, LLC | 500,000 | $1,180,000 | 1.98% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,227,114 | $2,896,000 | 0.86% |
| PERKINS CAPITAL MANAGEMENT INC | 232,166 | $548,000 | 0.66% |
| Stonepine Capital Management, LLC | 151,189 | $357,000 | 0.38% |
| Zebra Capital Management LLC | 84,963 | $200,000 | 0.32% |
| Intrinsic Edge Capital Management LLC | 1,000,000 | $2,360,000 | 0.31% |
| Alambic Investment Management, L.P. | 46,069 | $109,000 | 0.26% |
| OBERWEIS ASSET MANAGEMENT INC/ | 200,600 | $473,000 | 0.26% |